Annual Meeting Archives
2016
Category:
Overcoming Biological Barriers in Drug Delivery
Institutions:
(1) University of Toronto, Canada; (2) Princess Margaret Cancer Center, Canada
Category:
Preclinical Science Challenges to Drug Delivery
Institutions:
(1) UCL School of Pharmacy, University College London, United Kingdom
Category:
Local Drug Delivery
Institutions:
(1) Department of Biotechnology, The Catholic University of Korea, South Korea
Category:
Physical Oncology: Modulating Tumor Microenvironment for Drug Delivery
Institutions:
(1) University of Utah, U.S.A.
Category:
Overcoming Biological Barriers in Drug Delivery
Institutions:
(1) University of Minnesota, U.S.A.
Category:
Manufacture, Characterization, Stability, and Regulatory Aspects
Institutions:
(1) Flamac, a division of SIM, Belgium; (2) Ghent University, Belgium
Category:
Transdermal Delivery
Institutions:
(1) POSTECH, Korea
Category:
Encapsulation and Controlled Release for Industrial Applications
Institutions:
(1) West China School of Pharmacy, Sichuan University, China
Category:
Transdermal Delivery
Institutions:
(1) Queen's University Belfast, United Kingdom
Category:
Parenteral Systemic Delivery of Biopharmaceuticals: Overcoming Product Development and Regulatory Challenges
Institutions:
(1) Celator Pharmaceuticals Corp., Canada
Category:
Overcoming Biological Barriers in Drug Delivery
Institutions:
(1) McMaster University, Canada
Category:
Physical Oncology: Modulating Tumor Microenvironment for Drug Delivery
Institutions:
(1) University of Toronto, Canada; (2) Princess Margaret Cancer Center, Canada
Category:
Overcoming Biological Barriers in Drug Delivery
Institutions:
(1) University of Toronto, Canada; (2) Universidade Federal de Minas Gerais, Brazil
Category:
Oligonucleotide Delivery: New Applications and Opportunities
Institutions:
(1) Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, China
Category:
New Processes, New Materials, New Products
Institutions:
(1) Lotte Fine Chemicals, Korea
Category:
Integration of Imaging and Drug Delivery
Institutions:
(1) Stanford University, U.S.A.
Category:
Manufacture, Characterization, Stability, and Regulatory Aspects
Institutions:
(1) University of Alberta, Canada
Category:
Oral Delivery
Institutions:
(1) Gattefosse India Pvt. Ltd., India; (2) Institute of Chemical Technology, India
Category:
Tissue Engineering
Institutions:
(1) The University of Iowa, U.S.A.
Category:
Parenteral Systemic Delivery of Biopharmaceuticals: Overcoming Product Development and Regulatory Challenges
Institutions:
(1) Seoul National University, South Korea
Category:
Peptides, Proteins, and Vaccines
Institutions:
(1) SungKyunKwan University, Korea
Category:
Oligonucleotide Delivery: New Applications and Opportunities
Institutions:
(1) Alnylam Pharmaceuticals, U.S.A.
Category:
Integration of Imaging and Drug Delivery
Institutions:
(1) Institut Langevin (CNRS, ESPCI, INSERM), France; (2) IC2MP (Université de Poitiers, CNRS), CHU Poitiers, France; (3) MMN (ESPCI, CNRS, UPMC), France; (4) LCO (ESPCI, CNRS, UPMC), France; (5) IC2MP (Université de Poitiers, CNRS), France
Category:
Oral Delivery
Institutions:
(1) University of Belgrade - Faculty of Pharmacy, Serbia